Dr. Allen Nazeri breaks down eight factors that determine what healthcare companies are worth: revenue and EBITDA, operator risk, scalability, capex needs, whether the owner stays on, clean financials, competitive advantage, and recession resistance. He also flags emerging pressures like tech adoption, regulatory risk, and labor costs.
Questions this video answers
Dr Allen Nazeri, DDS MBA (creator/uploader).
April 30, 2025.
valuationsexits.com (contact shown as contact us today@valuationsexits.com).
Foreign.
When it comes to valuing healthcare companies, there isn't a one size fits all formula. The healthcare industry is diverse, covering primary care practices to biotech innovators, but certain factors consistently impact valuations across the board. Let's dive into the top eight factors that influence healthcare company valuation. First up, size of revenue and ebitda. Larger revenue and higher EBITDA typically attract higher valuation multiples. Buyers pay a premium for predictability and scale. Next key operator risk. If a business heavily relies on the owner, its valuation drops. Buyers prefer companies that run smoothly on systems and processes, not on a single individual's involvement. Third.
Investors look for businesses that can grow without a proportional increase in costs. Plug and play Scalable companies are exceptionally valuable. Fourth, capex requirements Businesses needing heavy ongoing investments in expensive equipment are less appealing. Low capex models are more attractive to buyers due to better cash flow. Fifth, the owner's willingness to stay and roll. Equity sellers willing to stay involved post transactions signal confidence in future growth, enticing higher valuations. Sixth, proper and clean financials Accurate, transparent financials are foundational. Clean books audited by reputable CPAs. Secure premium offers. 7th Economic Moat Sustainable competitive advantages like exclusive contracts or proprietary technology boost valuations by reducing future competition risks. 8th Recession resistance essential care sectors show resilience during downturns, attracting higher premiums. Emerging factors also play a role, such as technology adoption, regulatory risk, payer mix, labor dynamics and customer concentration. Valuing healthcare companies is both an art and a science. Each company's unique and subtle differences in these factors can significantly affect valuations. For those considering a sale, working with M and A advisors specializing in healthcare is crucial. They understand the operational, regulatory and market dynamics that drive value. By focusing on these eight pillars, you can position your healthcare business for maximum success during an exit. Thanks for watching. Don't forget to like subscribe and hit the bell icon to stay updated with Primexit's M&A advisory. For more insights and expert advice on healthcare, M and A and for a free valuation of your company, contact us today@valuationsexits.com.
